The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists? Ho WL, Wong H, Yau T Acta Ophthalmol. 2012 Sep 12. PMID: 22970709. Abstract CommentRecommendBookmarkWatch